Blank Bio
YC S25San Francisco, US · Founded 2025 · 6 employees · 1 known investors
Blank Bio develops RNA foundation models for precision oncology, helping pharmaceutical companies identify the right patients for clinical trials and predict disease progression using bulk RNA-seq data. The company applies AI to patient selection and disease trajectory modeling to improve clinical trial outcomes.
Founders & leadership· Y Combinator alumni (S25)
Investors · 1
In the news
- Blank Bio Raises $7.2M in Seed Fundingfinsmes.com · 2026
- Blank Bio secures $7.2 million to develop AI foundation models for RNA in oncologybio-research.ai · 2026
- Blank Bio raises $7.2M, inks PacBio RNA deal | PACB Stock Newsstocktitan.net · 2026
- Blank Bio: $7.2 Million Seed Financing Raised To Advance RNA Foundation Models For Precision Oncologypulse2.com · 2026
- Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncologybusinesswire.com · 2026
- Blank Bio - 2026 Company Profile, Team & Competitors - Tracxntracxn.com · 2026